| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Zimmer Biomet Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$148.08 |
| 52 Week High | US$171.80 |
| 52 Week Low | US$146.40 |
| Beta | 1.02 |
| 11 Month Change | 0.67% |
| 3 Month Change | -4.99% |
| 1 Year Change | n/a |
| 33 Year Change | -25.53% |
| 5 Year Change | n/a |
| Change since IPO | -5.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| Z1BH34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | 0.2% |
| 1Y | n/a | 21.3% | 3.9% |
Return vs Industry: Insufficient data to determine how Z1BH34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how Z1BH34 performed against the BR Market.
Price Volatility
| Z1BH34 volatility | |
|---|---|
| Z1BH34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 9.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: Z1BH34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine Z1BH34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 18,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products.
Zimmer Biomet Holdings, Inc. Fundamentals Summary
| Z1BH34 fundamental statistics | |
|---|---|
| Market cap | R$124.50b |
| Earnings (TTM) | R$6.15b |
| Revenue (TTM) | R$43.12b |
20.2x
P/E Ratio2.9x
P/S RatioIs Z1BH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| Z1BH34 income statement (TTM) | |
|---|---|
| Revenue | US$7.60b |
| Cost of Revenue | US$2.13b |
| Gross Profit | US$5.46b |
| Other Expenses | US$4.38b |
| Earnings | US$1.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.44 |
| Gross Margin | 71.90% |
| Net Profit Margin | 14.27% |
| Debt/Equity Ratio | 53.6% |
How did Z1BH34 perform over the long term?
See historical performance and comparison